Product Information

NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by PAI Holdings LLC, priced at $0.0584 per ML under NDC 00121086816. Its NADAC has been published 311 times since Sep 9, 2020.

FDA first approved this application on Jan 7, 2016. Its Orange Book therapeutic-equivalence code is AA.

NYSTATIN 100,000 UNIT/ML SUSP

NYSTATIN
$0.0584per ML

Strength

100000 [USP'U]/mL

Manufacturer

PAI Holdings LLC

NDC

00121086816

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

NYSTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA203621

FDA Approved

1/7/2016

TE Code

AA

On Market Since

7/17/2020

Pharmacological Classes

Price Statistics

The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 311 times since Sep 9, 2020, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0584 per ML
All-time high$0.0841 (Nov 11, 2020)
All-time low$0.0373 (Sep 21, 2022)
52-week high$0.0652
52-week low$0.0584
Median price$0.0563
Average price$0.0552
Largest weekly change+50.7% (Oct 21, 2020)
Weeks tracked311
Tracking sinceSep 9, 2020

Price History

1W

-0.2%

1M

-0.2%

3M

-3.4%

6M

-9.9%

1Y

-8.2%

3Y

+42.5%

5Y

+6.1%

All

-15.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by PAI Holdings LLC, is $0.0584 per ML (NDC 00121086816), effective Aug 19, 2026.

How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?

Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 15.1%. It has been tracked across 311 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?

Since Sep 9, 2020, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.0373 (Sep 21, 2022) to a high of $0.0841 (Nov 11, 2020), with a median of $0.0563 per ML.

Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0561 per ML — about 4% below NYSTATIN 100,000 UNIT/ML SUSP.

Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?

NYSTATIN 100,000 UNIT/ML SUSP (NDC 00121086816) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.